Xopenex Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Xopenex General Information

Description

Provider of healthcare services. The company manufactures a pharmaceutical under the Xopenex brand which is used in the treatment and prevention of bronchospasm in adults, adolescents and children.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • 84 Waterford Drive
  • Marlborough, MA 01752
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Xopenex Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Xopenex‘s full profile, request access.

Request a free trial

Xopenex Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Xopenex‘s full profile, request access.

Request a free trial